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INtroDUCtIoN 
Fever is a common manifestation in patients with systemic 
lupus erythematosus. Causes for fever in patients with 
lupus include disease activity, infection, malignancy and 
drug reactions. Neutropenia is defined as an ANC less 
than 1.5 x 109 /L. It occurs in about 50% of patients with 
lupus and can occur even when the patient is not in a 
flare. The neutropenia of lupus is usually due to peripheral 
destruction and not due to bone marrow suppression.
CAse PreseNtAtIoN
20 year old female with lupus nephritis controlled with 
mycophenolate mofeti, was admitted complaining of 
fever and intermittent chest pain. On admission, she had 
a temperature of 101.1 and negative cardiac studies.  
Blood work showed she was neutropenic with a WBC 
count of 1.6 and ANC of 0.1 thou/cmm including a few 
promyelocytes, myelocytes and metamyelocytes. Her 
renal function was normal. Further work up reveled 
low complement levels, elevated sedimentation 
rate, positive ANA, and elevated dsDNA antibodies. 
According to previous records, the patient had never 
been neutropenic. Physical exam of the patient was 
relatively unremarkable. Her chest pain was reproducible 
and localized to the right side of her chest and throat 
exam revealed one oral ulcer. No heptosplenomegaly, 
joint inflammation, or skin rash were seen. The patient 
was started on antibiotics, mycophenolate mofeti was 
stopped, and she was given filgrastim (Neupogen) which 
only transiently improved her ANC to normal limits.  
Despite these measures her fever persisted, further 
testing was done to look for the source of the infection, 
but all returned negative. Since fevers and neutropenia 
persisted without a source, a bone marrow biopsy was 
done revealing myelofibrosis with active granulopoiesis. 
The patient was negative for both JAK V617K mutation 
and BCL/ABL transcription, consistent with the diagnosis 
of autoimmune myelofibrosis. She was started on 
prednisone and within 48 hours was afebrile, feeling well 
and able to maintain normal ANC and WBC count.        
DIsCUssIoN
Patients with SLE often have hematologic abnormalities 
and fevers as a component of their disease. Autoimmune 
myelofibrosis is a rare cause of these abnormalities in 
patents with lupus, but should be considered when 
peripheral blood smears are abnormal. Bone marrow 
biopsy should be considered when myeloid/red blood 
cell precursors and tear drop cells are seen. Autoimmune 
myelofibrosis differs from primary myelofibrosis in the 
following ways:  
•	splenomegaly	is	rarely	seen
•		there	are	only	mild	numbers	of	(daptocytes)	or	tear	drop	
red cells and immature myeloid cells in the peripheral 
blood
•		patients	have	a	positive	direct	antiglobin	test	and	ANA,	
but negative JAK mutation and BCL/ABL transcription  
•		autoimmune	myelofibrosis	responds	well	to	steroids	
and IgG
This case exhibited an atypical cause for some common 
manifestations of lupus.
UPDAte 
The patient is clinically doing well, symptoms 
have resolved. She has been off of filgrastim 
(Neupogen) for over a month with stable 
neutrophil counts. For treatment, she is still 
undergoing a slow steroid taper, but her 
autoimmune markers have now normalized 
and she shows no clinical signs of disease 
activity. The patient was also seen at another 
institution where she had a repeat bone 
marrow biopsy which showed a significant 
decrease in myelofibrosis. The idea of acute 
megakaryoblastic leukemia with myelofibrosis 
was also entertained, but seems unlikely with 
the absence of dysmorphic cells in the bone 
marrow. This would be a rare and devastating 
cause for the patient’s symptoms, as few 
patients survive beyond three years with 
this diagnosis. Another idea currently being 
considered is whether the myelofibrosis 
is related to the mycophenolate mofeti. 
There are very rare reports of myelofibrosis 
developing in transplant patients who 
had been treated with cyclosporine A and 
mycophenolate mofeti. Patient currently 
remains off of mycophenolate mofeti.  
BoNe MArroW BIoPsY 
MYeLoFIBrosIs
NorMAL sPeCIMeN 
 Patient’s bone  
marrow biopsy  
with reticulin stain 
showing myelofibrosis
 Example of a normal specimen with H & E stain
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